SE0403160D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE0403160D0
SE0403160D0 SE0403160A SE0403160A SE0403160D0 SE 0403160 D0 SE0403160 D0 SE 0403160D0 SE 0403160 A SE0403160 A SE 0403160A SE 0403160 A SE0403160 A SE 0403160A SE 0403160 D0 SE0403160 D0 SE 0403160D0
Authority
SE
Sweden
Prior art keywords
compounds
disorders
related disorders
orexin
sup
Prior art date
Application number
SE0403160A
Other languages
English (en)
Inventor
Emma Barker
Annika Jenmalm Jensen
Erik Nordling
Andrew Proud
Martin Slater
Mikael Weber
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Priority to SE0403160A priority Critical patent/SE0403160D0/sv
Publication of SE0403160D0 publication Critical patent/SE0403160D0/sv
Priority to US11/318,126 priority patent/US20060217375A1/en
Priority to PCT/EP2005/057132 priority patent/WO2006067224A2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE0403160A 2004-12-23 2004-12-23 New compounds SE0403160D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0403160A SE0403160D0 (sv) 2004-12-23 2004-12-23 New compounds
US11/318,126 US20060217375A1 (en) 2004-12-23 2005-12-22 New compounds
PCT/EP2005/057132 WO2006067224A2 (en) 2004-12-23 2005-12-22 Spiro-benzodioxole and spiro-benzodioxane compounds as orexin receptor antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0403160A SE0403160D0 (sv) 2004-12-23 2004-12-23 New compounds

Publications (1)

Publication Number Publication Date
SE0403160D0 true SE0403160D0 (sv) 2004-12-23

Family

ID=34102109

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0403160A SE0403160D0 (sv) 2004-12-23 2004-12-23 New compounds

Country Status (2)

Country Link
US (1) US20060217375A1 (sv)
SE (1) SE0403160D0 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5524083B2 (ja) 2008-01-30 2014-06-18 セファロン、インク. ヒスタミン−3(h3)受容体リガンドとしての置換スピロ環状ピペリジン誘導体
MX2010008382A (es) * 2008-01-30 2010-11-25 Cephalon Inc Derivados de piperidina espirociclicos substituidos, como ligandos de receptores de histamina-3 (h3).
DE102008025893B4 (de) * 2008-05-26 2014-09-18 Technische Universität Dresden Verfahren zur Herstellung von Fettsäureamiden mit gesättigten, ungesättigten oder Hydroxy-Fettsäuren
WO2010044441A1 (ja) 2008-10-17 2010-04-22 塩野義製薬株式会社 血管内皮リパーゼ阻害活性を有する酢酸アミド誘導体

Also Published As

Publication number Publication date
US20060217375A1 (en) 2006-09-28

Similar Documents

Publication Publication Date Title
WO2006067224A3 (en) Spiro-benzodioxole and spiro-benzodioxane compounds as orexin receptor antagonists
JP6233454B2 (ja) Trk阻害化合物
NO20084318L (no) Inhibitorer av II-beta-hydroksystereoid dehydrogenase I
PH12016502294A1 (en) Novel fatty acids and their use in conjugation to biomolecules
CY1112398T1 (el) Πυρρολιδινονες υποκατασταθεισες απο κυκλοεξυλιο ως αναστολεις της 11-β-υδροξυστεροειδικης αφυδρογονασης 1
CY1109842T1 (el) Αναστολεις της αφυδρογονασης 11-β-υδροξυστεροειδων i
DE602006009095D1 (en) Diacylglycerol-acyltransferase-hemmer
EA200870475A1 (ru) Ингибиторы 11-бета-гидроксистероид-дегидрогеназы типа 1
WO2010036613A8 (en) Novel cyclic benzimidazole derivatives useful anti-diabetic agents
MY160256A (en) Novel indole compounds
DE602005013822D1 (de) Cycloalkylaminderivate
RU2010120808A (ru) Производное амина, обладающее активностью антагониста npy y5 рецептора, и его применение
EA200970088A1 (ru) Модуляторы метаболизма и лечение связанных с ним нарушений
CL2007002347A1 (es) Compuestos derivados de fenilo, piridina y quinolina; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de diabetes mellitus, trastornos en la tolerancia de la glucosa, obesidad, enfermedad de crohn, enferm
PE20120620A1 (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas
JP2009514837A5 (sv)
UY28774A1 (es) Derivados de heteroarilaminopirazol utiles para el tratamiento de la diabetes.
NO20062509L (no) Tetrazolderivater og fremgangsmater for behandling av stoffskifterelaterte forstyrrelser derav
JO2937B1 (en) Tight muscles of the peptide vascular tensioner receptor
GB0524814D0 (en) Compounds
DE602007013040D1 (de) 4-Ä(3-FLUORPHENOXY)PHENYLMETHYLÜPIPERIDINMETHANiSULFONAT: VERWENDUNGEN, SYNTHESEVERFAHREN UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
EA201000926A1 (ru) Пиперазины в качестве агентов против ожирения
WO2007144768A3 (en) Use of peptidic vasopressin receptor agonists
SE0403160D0 (sv) New compounds
CL2007002366A1 (es) Sales maleato, tosilato, fumarato y oxalato de 5-(1(s)-amino-2-hidroxietil)-n-[(2,4-difluorofenil)-metil]-2-[8-metoxi-2-(trifluorometil)-5-quinolin]-4-oxazolcarboxamida; proceso de preparacion de dichas sales, utiles para el tratamiento de afecciones